240 related articles for article (PubMed ID: 28536379)
1. Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview.
Polito L; Djemil A; Bortolotti M
Biomedicines; 2016 Jun; 4(2):. PubMed ID: 28536379
[TBL] [Abstract][Full Text] [Related]
2. Immunotoxins in cancer therapy: Review and update.
Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L
Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
[TBL] [Abstract][Full Text] [Related]
4. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
5. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
6. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
Rosenblum MG; Marks JW; Cheung LH
Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
[TBL] [Abstract][Full Text] [Related]
7. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
Brinkmann U
In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
[TBL] [Abstract][Full Text] [Related]
8. A novel method to purify immunotoxins from free antibodies using modified recombinant toxins.
Dhanabal M; Fryxell DK; Ramakrishnan S
J Immunol Methods; 1995 Jun; 182(2):165-75. PubMed ID: 7790724
[TBL] [Abstract][Full Text] [Related]
9. Ricin: An Ancient Story for a Timeless Plant Toxin.
Polito L; Bortolotti M; Battelli MG; Calafato G; Bolognesi A
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31174319
[TBL] [Abstract][Full Text] [Related]
10. Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins.
Giansanti F; Flavell DJ; Angelucci F; Fabbrini MS; Ippoliti R
Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29438358
[TBL] [Abstract][Full Text] [Related]
11. Prospects of bacterial and plant protein-based immunotoxins for treatment of cancer.
Weidle UH; Tiefenthaler G; Schiller C; Weiss EH; Georges G; Brinkmann U
Cancer Genomics Proteomics; 2014; 11(1):25-38. PubMed ID: 24633317
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells.
Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE
Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxins in the treatment of hematologic malignancies.
Kreitman RJ; Pastan I
Curr Drug Targets; 2006 Oct; 7(10):1301-11. PubMed ID: 17073592
[TBL] [Abstract][Full Text] [Related]
14. Plant-made immunotoxin building blocks: A roadmap for producing therapeutic antibody-toxin fusions.
Knödler M; Buyel JF
Biotechnol Adv; 2021; 47():107683. PubMed ID: 33373687
[TBL] [Abstract][Full Text] [Related]
15. Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners.
Tran M; Henry RE; Siefker D; Van C; Newkirk G; Kim J; Bui J; Mayfield SP
Biotechnol Bioeng; 2013 Nov; 110(11):2826-35. PubMed ID: 23719862
[TBL] [Abstract][Full Text] [Related]
16. Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells.
Polito L; Mercatelli D; Bortolotti M; Maiello S; Djemil A; Battelli MG; Bolognesi A
Toxins (Basel); 2017 May; 9(6):. PubMed ID: 28556822
[TBL] [Abstract][Full Text] [Related]
17. The activity of two immunotoxins composed of monoclonal antibody MoAb-16 and A-chain of ricin (MoAb-16-RTA) or A-chain of mistletoe lectin I (MoAb-16-MLIA).
Paprocka M; Wiedłocha A; Walzel H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):223-7. PubMed ID: 1300987
[TBL] [Abstract][Full Text] [Related]
18. Immunotoxin with mistletoe lectin I A-chain and ricin A-chain directed against CD5 antigen of human T-lymphocytes; comparison of efficiency and specificity.
Tonevitsky AG; Toptygin AYu ; Pfuller U; Bushueva TL; Ershova GV; Gelbin M; Pfuller K; Agapov II; Franz H
Int J Immunopharmacol; 1991; 13(7):1037-41. PubMed ID: 1722193
[TBL] [Abstract][Full Text] [Related]
19. Recombinant immunotoxins for cancer therapy.
Brinkmann U; Keppler-Hafkemeyer A; Hafkemeyer P
Expert Opin Biol Ther; 2001 Jul; 1(4):693-702. PubMed ID: 11727505
[TBL] [Abstract][Full Text] [Related]
20. Immunotoxins for targeted cancer therapy.
Pastan I; Kreitman RJ
Adv Drug Deliv Rev; 1998 Apr; 31(1-2):53-88. PubMed ID: 10837618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]